SHAWN AIKENS: Open Payments
NPI 1740823970 · BETHLEHEM, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$670 in 31 payments from 12 companies in 2025. Trend: 2023 $221 · 2024 $547 · 2025 $670
Food & beverage: $594Education: $76
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $108 |
| Janssen Pharmaceuticals, Inc | 4 | $100 |
| ABBVIE INC. | 5 | $77 |
| Neurocrine BioSciences, Inc. | 3 | $72 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| E.R. Squibb & Sons, L.L.C. | 2 | $49 |
| Alkermes, Inc. | 2 | $47 |
| Lundbeck LLC | 3 | $47 |
| Collegium Pharmaceutical, Inc. | 3 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
Products named: SPRAVATO, VRAYLAR, INGREZZA, REXULTI, COBENFY, Jornay PM, VIVITROL, CAPLYTA.
Industry payments across PA — which companies pay providers there.
